Search

Your search keyword '"Schubert JK"' showing total 86 results

Search Constraints

Start Over You searched for: Author "Schubert JK" Remove constraint Author: "Schubert JK"
86 results on '"Schubert JK"'

Search Results

5. Protocol for visualizing complex volatile metabolomics data in clinical setups using EDaViS software.

6. Effects of Contagious Respiratory Pathogens on Breath Biomarkers.

7. Origin of breath isoprene in humans is revealed via multi-omic investigations.

8. Advanced setup for safe breath sampling and patient monitoring under highly infectious conditions in the clinical environment.

9. Profiling of exhaled volatile organics in the screening scenario of a COVID-19 test center.

10. Effects of COVID-19 protective face masks and wearing durations on respiratory haemodynamic physiology and exhaled breath constituents.

11. Real-time metabolic monitoring under exhaustive exercise and evaluation of ventilatory threshold by breathomics: Independent validation of evidence and advances.

12. Non-Invasive O-Toluidine Monitoring during Regional Anaesthesia with Prilocaine and Detection of Accidental Intravenous Injection in an Animal Model.

13. Breath chemical markers of sexual arousal in humans.

14. Physiological and metabolic effects of healthy female aging on exhaled breath biomarkers.

15. Detection of Paratuberculosis in Dairy Herds by Analyzing the Scent of Feces, Alveolar Gas, and Stable Air.

16. Detection of Mycobacterium avium ssp. paratuberculosis in Cultures From Fecal and Tissue Samples Using VOC Analysis and Machine Learning Tools.

17. Deficiency and absence of endogenous isoprene in adults, disqualified its putative origin.

18. Spatial mapping of VOC exhalation by means of bronchoscopic sampling.

19. Effects of modular ion-funnel technology onto analysis of breath VOCs by means of real-time mass spectrometry.

20. Exhaled breath compositions under varying respiratory rhythms reflects ventilatory variations: translating breathomics towards respiratory medicine.

21. Changes of Exhaled Volatile Organic Compounds in Postoperative Patients Undergoing Analgesic Treatment: A Prospective Observational Study.

23. Volatile scents of influenza A and S. pyogenes (co-)infected cells.

24. Extending PTR based breath analysis to real-time monitoring of reactive volatile organic compounds.

25. Exhaled volatile substances in children suffering from type 1 diabetes mellitus: results from a cross-sectional study.

26. Non-Invasive Assessment of Metabolic Adaptation in Paediatric Patients Suffering from Type 1 Diabetes Mellitus.

27. Core profile of volatile organic compounds related to growth of Mycobacterium avium subspecies paratuberculosis - A comparative extract of three independent studies.

28. Crowd monitoring in dairy cattle-real-time VOC profiling by direct mass spectrometry.

29. Differences in the Emission of Volatile Organic Compounds (VOCs) between Non-Differentiating and Adipogenically Differentiating Mesenchymal Stromal/Stem Cells from Human Adipose Tissue.

30. Effects of elevated oxygen levels on VOC analysis by means of PTR-ToF-MS.

31. VOC breath profile in spontaneously breathing awake swine during Influenza A infection.

32. Evaluation of needle trap micro-extraction and solid-phase micro-extraction: Obtaining comprehensive information on volatile emissions from in vitro cultures.

33. Natural menstrual rhythm and oral contraception diversely affect exhaled breath compositions.

34. Versatile set-up for non-invasive in vitro analysis of headspace VOCs.

35. Continuous real-time breath analysis in ruminants: effect of eructation on exhaled VOC profiles.

36. Can Recognition of Spinal Ischemia Be Improved? Application of Motor-Evoked Potentials, Serum Markers, and Breath Gas Analysis in an Acutely Instrumented Pig Model.

37. Effects of humidity, CO 2 and O 2 on real-time quantitation of breath biomarkers by means of PTR-ToF-MS.

38. Safety and applicability of a pre-stage public access ventilator for trained laypersons: a proof of principle study.

39. Strategies for the identification of disease-related patterns of volatile organic compounds: prediction of paratuberculosis in an animal model using random forests.

40. Applied upper-airway resistance instantly affects breath components: a unique insight into pulmonary medicine.

41. Exhaled volatile substances mirror clinical conditions in pediatric chronic kidney disease.

42. Drug detection in breath: non-invasive assessment of illicit or pharmaceutical drugs.

43. Monitoring of breath VOCs and electrical impedance tomography under pulmonary recruitment in mechanically ventilated patients.

44. Effects of biological and methodological factors on volatile organic compound patterns during cultural growth of Mycobacterium avium ssp. paratuberculosis.

45. FEV manoeuvre induced changes in breath VOC compositions: an unconventional view on lung function tests.

46. High intravascular tissue factor-but not extracellular microvesicles-in septic patients is associated with a high SAPS II score.

47. Instant effects of changing body positions on compositions of exhaled breath.

48. In Vivo Volatile Organic Compound Signatures of Mycobacterium avium subsp. paratuberculosis.

49. Electrochemical sensor system for breath analysis of aldehydes, CO and NO.

50. Detection of gaseous compounds by needle trap sampling and direct thermal-desorption photoionization mass spectrometry: concept and demonstrative application to breath gas analysis.

Catalog

Books, media, physical & digital resources